首页> 美国卫生研究院文献>The Journal of International Medical Research >Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention

【2h】

Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention

机译：急性冠状动脉综合征患者中急性冠状动脉综合征患者中嗜中性粒细胞对淋巴细胞比率与急性冠状动脉综合征患者进行经皮冠状动脉介入的疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

We aimed to explore the relationship between neutrophil-to-lymphocyte ratio (NLR) at three timepoints and prognosis of patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) undergoing elective percutaneous coronary intervention (PCI) within 1 year of PCI.

机译：我们旨在探讨中性粒细胞对淋巴细胞比率（NLR）在1年内接受早期冠状动脉综合征（PCI）的非ST段抬高急性冠状动脉综合征（NSTE-AC）的患者预后的关系PCI。

著录项

期刊名称 The Journal of International Medical Research
作者
Zhisong Wang; Juan Wang; Donglai Cao; Leng Han;
展开▼
作者单位

展开▼
年(卷),期 2020(48),10
年度 2020
页码 0300060520959510
总页数 11
原文格式 PDF
正文语种
中图分类药学;医学史;
关键词
Neutrophil-to-lymphocyte ratio; major cardiovascular event; major cerebrovascular adverse event; non-ST-elevation acute coronary syndrome; percutaneous coronary intervention; left ventricular ejection fraction; risk factor;

机译：中性粒细胞到淋巴细胞比例;主要的心血管事件;主要脑血管逆事件;非ST-EXTATION急性冠状动脉综合征;经皮冠状动脉介入;左心室喷射分数;危险因素;
入库时间 2022-08-21 12:01:31

相似文献

外文文献
中文文献
专利

1. Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention [J] . Zhisong Wang, Juan Wang, Donglai Cao, Journal of International Medical Research . 2020,第10期

机译：急性冠状动脉综合征患者中急性冠状动脉综合征患者中嗜中性粒细胞对淋巴细胞比率与急性冠状动脉综合征患者进行经皮冠状动脉介入的疗效
2. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high-risk non-ST-segment elevation acute coronary syndromes patients: An analysis from the Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome trial [J] . BagaiA., WhiteJ.A., LokhnyginaY., The American heart journal . 2013,第3期

机译：高危非ST段抬高的急性冠脉综合征患者经皮冠状动脉介入治疗的常规早期依替非巴肽与延迟临时使用：从非ST段抬高的急性冠状动脉综合征试验中早期糖蛋白IIb / IIIa抑制作用的分析
3. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: An early ACS (Early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome) angiographic substudy [J] . PrideY.B., MohanaveluS., ZorkunC., JACC. Cardiovascular interventions . 2012,第9期

机译：经皮冠状动脉介入治疗的急性冠状动脉综合征患者的血管造影并发症与临床结局之间的关联：早期ACS（非ST段抬高急性冠脉综合征中的早期糖蛋白IIb / IIIa抑制）血管造影研究
4. Influence of Diabetes Mellitus in patients with Long Coronary Lesions Undergoing Percutaneous Coronary Interventions: Multicenter PCI Registry in Japan [C] . E. Saito, M. Hirose, T. Miyauchi, International Congress on Coronary Artery Disease . 2003

机译：经皮冠状动脉干预患者糖尿病患者糖尿病的影响：日本多中心PCI登记处
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Comparison of enoxaparin and unfractionated heparin in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: a systematic review and meta-analysis [O] . Pengcheng He, Yuanhui Liu, Xuebiao Wei, 2018

机译：非ST段抬高急性冠脉综合征经皮冠状动脉介入治疗患者中依诺肝素和普通肝素的比较：系统评价和荟萃分析
7. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery [O] . Glenn N. Levine, Eric R. Bates, John A. Bittl, 2016

机译：2016年ACC / AHA指南重点是冠心病患者双抗血小板治疗持续时间的重点：美国心脏病学 - 美国心脏病学院/美国心脏关联工作队的报告临床实践指南：2011年ACCF / AHA / SCAI指南的更新对于经皮冠状动脉干预，2011年冠状动脉旁路接枝外科手术，2012年ACC / AHA / ACP / AATS / PCNA / SCAI / STS指南诊断和管理稳定缺血性心脏病患者，2013年ACCF / AHA指南对于管理ST升高的心肌梗死，2014年AHA / ACC治疗非ST-EXTIVATION急性冠状动脉综合征的患者，2014年ACC / AHA指南围手术期心血管评估和管理患者患者患者

Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention

摘要

著录项

相似文献

相关主题

期刊订阅